Загрузка...
A randomized phase II trial of interleukin 2 and interleukin 2-interferon alpha in advanced renal cancer.
A randomized phase II trial was performed to compare the efficacy and toxicity of interleukin 2 (IL-2) with an IL-2 and interferon alpha (IFN-alpha) regimen for the treatment of metastatic renal carcinoma. Sixty patients with recurrent renal cell carcinoma (RCC) who had previously undergone a nephre...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group|1
1998
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2063040/ https://ncbi.nlm.nih.gov/pubmed/9703284 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|